SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 142 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 5.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,379,000 | -85.4% | 216,307 | -87.0% | 1.28% | -86.0% |
| Q1 2017 | $16,300,000 | +20.8% | 1,663,281 | +33.1% | 9.19% | +14.3% |
| Q4 2016 | $13,491,000 | -4.6% | 1,249,200 | +15.4% | 8.04% | -44.6% |
| Q2 2016 | $14,138,000 | -37.3% | 1,082,532 | -47.2% | 14.50% | -45.5% |
| Q1 2016 | $22,535,000 | +108.4% | 2,048,638 | +74.3% | 26.58% | +109.8% |
| Q4 2015 | $10,815,000 | – | 1,175,574 | – | 12.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
| Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
| Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
| MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
| Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
| TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
| Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
| GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
| Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |